| 发明名称 |
COMPOUNDS AND METHOD FOR TREATMENT OF CANCER |
| 摘要 |
<p>The present invention is directed to a compound of Formula I: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, or combination thereof, a composition comprising the thiosemicarbazone, a method of administration thereof, and use thereof to treat a cancer.</p> |
| 申请公布号 |
EP2121681(B1) |
申请公布日期 |
2015.04.15 |
| 申请号 |
EP20080700510 |
申请日期 |
2008.01.11 |
| 申请人 |
CRITICAL OUTCOME TECHNOLOGIES, INC. |
发明人 |
DANTER, WAYNE R.;BROWN, MARTYN;LEPIFRE, FRANCK |
| 分类号 |
C07D471/04;A61K31/496;A61P35/00;C07D401/14;C07D471/14 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
